Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-027864
Filing Date
2020-10-08
Accepted
2020-10-08 19:47:02
Documents
2
Period of Report
2020-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4671
2 EX-24 DOCUMENT attachment1.htm EX-24 3983
  Complete submission text file 0000899243-20-027864.txt   10003
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Gibson Neil W (Reporting) CIK: 0001555918 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39593 | Film No.: 201231870

Mailing Address 1018 W. 11TH STREET AUSTIN TX 78703
Business Address 1018 W. 11TH STREET AUSTIN TX 78703 919-864-2700
Shattuck Labs, Inc. (Issuer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations